C.Q. Pharmaceutical Holding Co Ltd

Chongqing Pharmaceutical recently announced that it completed the cancellation procedures for 15.4066 million repurchased shares on July 8, 2026. The cancelled repurchased shares accounted for 0.8915% of the total share capital before cancellation. After the cancellation, the total share capital decreased from 1.728 billion shares to 1.713 billion shares. The company previously approved a repurchase plan to use its own funds and special loans to repurchase shares through centralized bidding for capital reduction, with a total repurchase amount of no less than 80 million yuan and no more than 100 million yuan, and a repurchase price not exceeding 6.6 yuan per share. As of July 2, 2026, the company had repurchased a total of 15.4066 million shares, with the highest transaction price at 5.48 yuan per share and the lowest at 5.01 yuan per share, paying approximately 80.9988 million yuan. The repurchase plan has been fully implemented. The company stated that this cancellation will not have a significant impact on its operations, finances, research and development, debt repayment capabilities, or future development.

On the evening of July 9, multiple A-share listed companies issued announcements on share buybacks and stake increases. Neusoft announced that, because its stock price is below net asset value per share, it plans to buy back shares worth 100 million to 200 million yuan and cancel them all. Based on a maximum buyback price of 11.67 yuan per share, the number of shares to be repurchased is approximately 8.57 million to 17.14 million, accounting for 0.72% to 1.43% of total share capital. Yibai Pharmaceutical will cancel 7.53 million repurchased shares, representing 0.95% of total share capital, after which total share capital will change to 784 million shares. Unigroup Guoxin will cancel 6.40 million shares because the repurchased shares were not used for an incentive plan within 36 months. Sansure Biotech will cancel 4.45 million shares to reduce registered capital, aiming to boost earnings per share. Chongqing Pharmaceutical has completed the cancellation procedures for 15.41 million repurchased shares. Dazhong Mining made its first buyback of 580,000 shares, with a transaction amount of 17.51 million yuan. Jiayi Holdings made its first buyback of 64,200 shares, with a transaction amount of 1.99 million yuan. Qingmu Technology plans to buy back shares worth 20 million to 30 million yuan for incentive purposes. On the stake increase side, Sheng Jianhua, one of the actual controllers of Xidian New Energy, increased his stake by 614,900 shares, with an amount of 19.45 million yuan. Actual controllers Sheng Jianhua and Pan Shuxin plan to increase their combined stake by 10 million to 20 million yuan. The controlling shareholder of Shenghang Shipping, Wanda Holding Group, plans to increase its stake by no more than 6.10 million shares, with an amount of 66 million to 96 million yuan. Liu Xiaodong, the actual controller of Bairun Holdings, increased his stake by 1.12 million shares, with an amount of 17.98 million yuan, and plans to continue increasing his stake by 50 million to 100 million yuan. Some directors and senior executives of Longxi Bearing increased their combined stake by 67,400 shares, with an amount of 909,400 yuan.